Not yet medically reviewed, information on this site is in preparation and has not been verified by a medical reviewer.
Drug index / Prescription / Pregabalin
Prescription

Pregabalin

(3S)-3-(aminomethyl)-5-methylhexanoic acid

Pregabalin (brand name Lyrica) is a prescription gabapentinoid approved to treat neuropathic pain, fibromyalgia, and partial-onset seizures. Structurally related to GABA, it acts on calcium channels rather than GABA receptors. It is a Schedule V controlled substance in the U.S. — the lowest control tier — reflecting a real but relatively low potential for misuse and dependence, which is highest among people with a history of opioid use.

Overview

Pregabalin, approved in the U.S. in 2004, is the more potent and faster-absorbed of the two main gabapentinoids (the other being gabapentin). It is FDA-approved for nerve pain from diabetes and shingles, spinal-cord-injury pain, fibromyalgia, and as add-on therapy for partial-onset seizures, and is used off-label for generalized anxiety. Unlike gabapentin, it was classified as a federally controlled substance from its release, reflecting recognized abuse potential.

Source: FDA; peer-reviewed literature (NIH/PMC)

Chemistry & mechanism of action

Pregabalin is structurally similar to the neurotransmitter GABA but does not act on GABA receptors. Like gabapentin, it binds the alpha-2-delta subunit of voltage-gated calcium channels in the central nervous system, reducing the release of excitatory neurotransmitters and thereby calming overactive nerve signaling. It is absorbed more efficiently and predictably than gabapentin, which contributes to both its faster onset and its somewhat higher misuse potential.

Source: peer-reviewed pharmacology literature (NIH/PMC)

Effects

At therapeutic doses pregabalin causes dizziness, drowsiness, and fluid retention, and is more likely than gabapentin to cause weight gain. When misused at high doses, users report sedation, euphoria, and relaxation. Tolerance develops with sustained heavy use, and misuse frequently occurs alongside opioids to intensify their effects — a pattern documented in people with opioid use disorder taking very large daily doses.

Source: FDA; peer-reviewed literature (NIH/PMC)

Risks & harms

As with gabapentin, the FDA's December 2019 warning flags serious, life-threatening, and fatal respiratory depression, especially when pregabalin is combined with opioids or other CNS depressants or used by people with compromised breathing. Physical dependence can develop, and abrupt discontinuation after regular use produces a withdrawal syndrome that can be severe — anxiety, insomnia, sweating, and body aches — so it must be tapered rather than stopped suddenly. Misuse and dependence risk is greatest in people with existing substance use disorders, particularly opioid use disorder, where high-dose pregabalin dependence and difficult withdrawals are well documented. The label also carries warnings about suicidal thoughts and behavior.

Source: FDA; peer-reviewed literature (NIH/PMC)

Images

Visual references coming soon.

If it’s too intense

If an experience becomes overwhelming, the goal is to stay safe and let it pass, most difficult experiences ease as the drug wears off.

  • Get to a calm, safe space with someone you trust who is sober and can stay with you.
  • Cool down if you’re overheating, move somewhere cool, remove extra layers, rest. Overheating is especially a risk with stimulants and MDMA.
  • Sip water to thirst, but don’t over-hydrate. Drinking large amounts of plain water (especially after MDMA) can dangerously dilute your blood sodium (hyponatremia). Electrolytes help more than volume.
  • Slow your breathing, long, slow exhales help settle a racing heart and anxiety.
  • A sugary drink, fruit juice, or a snack can ease shakiness and the anxiety that comes with low blood sugar.
  • Do not take more, and do not add another substance to manage it. Redosing or adding something else (including a sedative like a benzodiazepine) can make things worse, not better.
Call 911 (or Poison Control, 1-800-222-1222) right away for chest pain, a very high body temperature, a seizure, unconsciousness, or severe confusion. These are medical emergencies, not something to wait out.

Source: general harm-reduction guidance from SAMHSA, NIH/NIDA, and MedlinePlus, in our own words. Draft, not yet medically reviewed.

Forensic dossier

Draft · every field is source-cited or marked “Unknown, pending review”

Identity

IUPAC name
(3S)-3-(aminomethyl)-5-methylhexanoic acidPubChem PUG-REST ↗ · retrieved 2026-06-18
InChIKey
AYXYPKUFHZROOJ-ZETCQYMHSA-NPubChem PUG-REST ↗ · retrieved 2026-06-18
Synonyms / aliases
lyrica, Lyrica, 3-isobutyl GABA, Pregabaline, Pregabalina, Vronogabic, Pregabalin mylan, Pregabalin sandoz, Pregabalin zentiva, (R-)-3-isobutyl GABA, Pregabalin sandoz gmbhPubChem PUG-REST + seed aliases ↗ · retrieved 2026-06-18

Composition

Composition
N/A — single compound (see Identity)

Physical / pill characteristics

Dosage form
3 DOSAGE FORMS AND STRENGTHS Capsules: 25 mg, 50 mg, 75 mg, 100 mg, 150 mg, 200 mg, 225 mg, and 300 mg [see Description (11) and How Supplied/Storage and HandliopenFDA drug label ↗ · retrieved 2026-06-18
Shape
Unknown — pending review (verify tablet imprint/shape against NLM Pillbox/DailyMed; N/A if not an oral tablet)
Color
Unknown — pending review (verify tablet imprint/shape against NLM Pillbox/DailyMed; N/A if not an oral tablet)
Imprint
Unknown — pending review (verify tablet imprint/shape against NLM Pillbox/DailyMed; N/A if not an oral tablet)
Score
Unknown — pending review (verify tablet imprint/shape against NLM Pillbox/DailyMed; N/A if not an oral tablet)

Scheduling & legal status

US schedule
Unknown — pending review
International
Unknown, pending review

Effects, risks & interactions

Effects
Pregabalin is a gabapentinoid — it binds a subunit of voltage-gated calcium channels to dampen the release of excitatory neurotransmitters — used for nerve pain, seizures and anxiety. Its effects are calming and analgesic; at higher-than-prescribed exposure it can produce relaxation, euphoria and a sense of wellbeing, which underlies its misuse. Compared with gabapentin it is more potent and is absorbed more completely and predictably, which gives it a notably higher abuse liability.PubChem CID 5486971 + DailyMed Lyrica ↗ · retrieved 2026-06-18
Risks
Pregabalin's most important safety concern is respiratory depression, particularly when it is combined with opioids — together they can dangerously suppress breathing, a well-recognised and sometimes fatal interaction. It can also cause drowsiness, dizziness, impaired coordination, swelling and weight gain, and it produces dependence with a withdrawal syndrome on stopping. Its efficient absorption and greater potency make it both more sought-after and more dangerous to misuse than gabapentin, and its depressant effect is amplified by alcohol and other sedatives.PubChem CID 5486971 + DailyMed Lyrica ↗ · retrieved 2026-06-18
Interactions
Pregabalin undergoes negligible metabolism and is excreted largely unchanged, so it has few of the liver-enzyme drug interactions that many medicines do — but its labelling foregrounds the additive danger with other CNS depressants, and especially with opioids: together they can cause severe sedation, respiratory depression and death. Alcohol and other sedatives similarly compound its effects.DailyMed Lyrica §7 ↗ · retrieved 2026-06-18

Pill catalog

Rx/OTC variants · openFDA + DailyMed (public domain) · draft, pending review

This drug comes in 508different versions. Make sure you’re looking at the right one, use the search above to find your exact pill by imprint, color, or shape.

Showing 24 of 508 variants

AN 1311
Illustration based on reported characteristics. Appearance varies, identical-looking pills can contain completely different substances. Always test.
Strength
PREGABALIN 50 mg/1
Imprint
AN 1311
Color
white
Shape
CAPSULE
Form
CAPSULE
Labeler
Amneal Pharmaceuticals NY LLC
Schedule
CV
NDC
69238-1311 ↗ · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies, identical-looking pills can contain completely different substances. Always test.
Strength
PREGABALIN 50 mg/1
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
CAPSULE
Labeler
Direct_Rx
Schedule
CV
NDC
72189-019 ↗ · 2026-06-18
SK F PG100
Illustration based on reported characteristics. Appearance varies, identical-looking pills can contain completely different substances. Always test.
Strength
PREGABALIN 100 mg/1
Imprint
SK F PG100
Color
orange
Shape
CAPSULE
Form
CAPSULE
Labeler
Eskayef Pharmaceuticals Limited
Schedule
CV
NDC
72658-0811 ↗ · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies, identical-looking pills can contain completely different substances. Always test.
Strength
PREGABALIN 50 mg/1
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
CAPSULE
Labeler
Major Pharmaceuticals
Schedule
CV
NDC
0904-6992 ↗ · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies, identical-looking pills can contain completely different substances. Always test.
Strength
PREGABALIN 50 mg/1
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
CAPSULE
Labeler
Bryant Ranch Prepack
Schedule
CV
NDC
71335-1751 ↗ · 2026-06-18
SK F PG25
Illustration based on reported characteristics. Appearance varies, identical-looking pills can contain completely different substances. Always test.
Strength
PREGABALIN 25 mg/1
Imprint
SK F PG25
Color
white
Shape
CAPSULE
Form
CAPSULE
Labeler
Eskayef Pharmaceuticals Limited
Schedule
CV
NDC
72658-0808 ↗ · 2026-06-18
Cipla300mg
Illustration based on reported characteristics. Appearance varies, identical-looking pills can contain completely different substances. Always test.
Strength
PREGABALIN 300 mg/1
Imprint
Cipla300mg 685
Color
ORANGE
Shape
CAPSULE
Form
CAPSULE
Labeler
Cipla USA Inc.
Schedule
CV
NDC
69097-685 ↗ · 2026-06-18
SK F PG50
Illustration based on reported characteristics. Appearance varies, identical-looking pills can contain completely different substances. Always test.
Strength
PREGABALIN 50 mg/1
Imprint
SK F PG50
Color
white
Shape
CAPSULE
Form
CAPSULE
Labeler
Eskayef Pharmaceuticals Limited
Schedule
CV
NDC
72658-0809 ↗ · 2026-06-18
AN 1310
Illustration based on reported characteristics. Appearance varies, identical-looking pills can contain completely different substances. Always test.
Strength
PREGABALIN 25 mg/1
Imprint
AN 1310
Color
white
Shape
CAPSULE
Form
CAPSULE
Labeler
Amneal Pharmaceuticals NY LLC
Schedule
CV
NDC
69238-1310 ↗ · 2026-06-18
SK F PG75
Illustration based on reported characteristics. Appearance varies, identical-looking pills can contain completely different substances. Always test.
Strength
PREGABALIN 75 mg/1
Imprint
SK F PG75
Color
white
Shape
CAPSULE
Form
CAPSULE
Labeler
Eskayef Pharmaceuticals Limited
Schedule
CV
NDC
72658-0810 ↗ · 2026-06-18
SG 354
Illustration based on reported characteristics. Appearance varies, identical-looking pills can contain completely different substances. Always test.
Strength
PREGABALIN 150 mg/1
Imprint
SG 354
Color
white
Shape
CAPSULE
Form
CAPSULE
Labeler
ScieGen Pharmaceuticals, Inc
Schedule
CV
NDC
50228-649 ↗ · 2026-06-18
145 J
Illustration based on reported characteristics. Appearance varies, identical-looking pills can contain completely different substances. Always test.
Strength
PREGABALIN 300 mg/1
Imprint
145 J
Color
white
Shape
CAPSULE
Form
CAPSULE
Labeler
NorthStar RxLLC
Schedule
CV
NDC
72603-358 ↗ · 2026-06-18
SG 351
Illustration based on reported characteristics. Appearance varies, identical-looking pills can contain completely different substances. Always test.
Strength
PREGABALIN 50 mg/1
Imprint
SG 351
Color
white
Shape
CAPSULE
Form
CAPSULE
Labeler
ScieGen Pharmaceuticals, Inc
Schedule
CV
NDC
50228-646 ↗ · 2026-06-18
CC 04 75
Illustration based on reported characteristics. Appearance varies, identical-looking pills can contain completely different substances. Always test.
Strength
PREGABALIN 75 mg/1
Imprint
CC 04 75
Color
white
Shape
CAPSULE
Form
CAPSULE
Labeler
Chartwell RX, LLC
Schedule
CV
NDC
62135-445 ↗ · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies, identical-looking pills can contain completely different substances. Always test.
Strength
PREGABALIN 50 mg/1
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
CAPSULE
Labeler
Preferred Pharmaceuticals Inc.
Schedule
CV
NDC
68788-8472 ↗ · 2026-06-18
141 J
Illustration based on reported characteristics. Appearance varies, identical-looking pills can contain completely different substances. Always test.
Strength
PREGABALIN 100 mg/1
Imprint
141 J
Color
orange
Shape
CAPSULE
Form
CAPSULE
Labeler
NorthStar RxLLC
Schedule
CV
NDC
72603-355 ↗ · 2026-06-18
SG 352
Illustration based on reported characteristics. Appearance varies, identical-looking pills can contain completely different substances. Always test.
Strength
PREGABALIN 75 mg/1
Imprint
SG 352
Color
white
Shape
CAPSULE
Form
CAPSULE
Labeler
ScieGen Pharmaceuticals, Inc
Schedule
CV
NDC
50228-647 ↗ · 2026-06-18
CC 04 100
Illustration based on reported characteristics. Appearance varies, identical-looking pills can contain completely different substances. Always test.
Strength
PREGABALIN 100 mg/1
Imprint
CC 04 100
Color
brown
Shape
CAPSULE
Form
CAPSULE
Labeler
Chartwell RX, LLC
Schedule
CV
NDC
62135-446 ↗ · 2026-06-18
142 J
Illustration based on reported characteristics. Appearance varies, identical-looking pills can contain completely different substances. Always test.
Strength
PREGABALIN 150 mg/1
Imprint
142 J
Color
white
Shape
CAPSULE
Form
CAPSULE
Labeler
NorthStar RxLLC
Schedule
CV
NDC
72603-356 ↗ · 2026-06-18
SG 353
Illustration based on reported characteristics. Appearance varies, identical-looking pills can contain completely different substances. Always test.
Strength
PREGABALIN 100 mg/1
Imprint
SG 353
Color
orange
Shape
CAPSULE
Form
CAPSULE
Labeler
ScieGen Pharmaceuticals, Inc
Schedule
CV
NDC
50228-648 ↗ · 2026-06-18
CC 04 150
Illustration based on reported characteristics. Appearance varies, identical-looking pills can contain completely different substances. Always test.
Strength
PREGABALIN 150 mg/1
Imprint
CC 04 150
Color
white
Shape
CAPSULE
Form
CAPSULE
Labeler
Chartwell RX, LLC
Schedule
CV
NDC
62135-447 ↗ · 2026-06-18
143 J
Illustration based on reported characteristics. Appearance varies, identical-looking pills can contain completely different substances. Always test.
Strength
PREGABALIN 200 mg/1
Imprint
143 J
Color
orange
Shape
CAPSULE
Form
CAPSULE
Labeler
NorthStar RxLLC
Schedule
CV
NDC
72603-357 ↗ · 2026-06-18
SG 355
Illustration based on reported characteristics. Appearance varies, identical-looking pills can contain completely different substances. Always test.
Strength
PREGABALIN 200 mg/1
Imprint
SG 355
Color
orange
Shape
CAPSULE
Form
CAPSULE
Labeler
ScieGen Pharmaceuticals, Inc
Schedule
CV
NDC
50228-650 ↗ · 2026-06-18
SG 356
Illustration based on reported characteristics. Appearance varies, identical-looking pills can contain completely different substances. Always test.
Strength
PREGABALIN 225 mg/1
Imprint
SG 356
Color
white
Shape
CAPSULE
Form
CAPSULE
Labeler
ScieGen Pharmaceuticals, Inc
Schedule
CV
NDC
50228-651 ↗ · 2026-06-18

Dosage

Pending medical reviewer

Sources

← Back to the drug index